Capricor Therapeutics (NasdaqCM:CAPR) Update / Briefing September 25, 2025 08:30 AM ET Company ParticipantsAJ Bergmann - CFOLinda Marbán - CEO & DirectorJoe Pantginis - Managing Director, Equity ResearchAydin Huseynov - Managing Director, Equity ResearchCatherine Novack - Director - HealthcareRohan Mathur - Biopharma Equity Research AssociateConference Call ParticipantsKristen Kluska - Equity Research AnalystMadison Elsaadi - Equity Research Analyst - HealthcareEdward Tenthoff - MD & Senior Research Analyst ...